ING GROEP NV - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
ING GROEP NV ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$429,000
-21.1%
145,8660.0%0.01%
-41.7%
Q1 2019$544,000
+94.3%
145,866
+108.4%
0.01%
+100.0%
Q4 2018$280,000
-28.0%
70,0000.0%0.01%
-14.3%
Q3 2018$389,000
+17.9%
70,0000.0%0.01%
+16.7%
Q1 2018$330,000
+14.2%
70,0000.0%0.01%
+20.0%
Q4 2017$289,000
-34.9%
70,0000.0%0.01%
-44.4%
Q3 2017$444,000
+182.8%
70,000
+250.0%
0.01%
+200.0%
Q2 2017$157,000
-72.6%
20,000
-76.9%
0.00%
-70.0%
Q1 2017$574,000
-4.3%
86,7190.0%0.01%
-9.1%
Q4 2016$600,000
-25.3%
86,7190.0%0.01%
+10.0%
Q3 2016$803,000
+0.2%
86,7190.0%0.01%
-9.1%
Q2 2016$801,000
-13.7%
86,719
-18.7%
0.01%
-8.3%
Q1 2016$928,000
-69.8%
106,719
-76.6%
0.01%
-33.3%
Q4 2015$3,071,000
+396.9%
456,719
+326.4%
0.02%
+350.0%
Q3 2015$618,000
-81.6%
107,103
-73.9%
0.00%
-77.8%
Q2 2015$3,351,000
+2538.6%
410,719
+2532.8%
0.02%
+1700.0%
Q1 2015$127,00015,6000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
CAXTON ASSOCIATES LP 784,679$643,4370.10%
Green Alpha Advisors, LLC 146,300$119,9660.08%
Virtus ETF Advisers LLC 54,106$44,3670.02%
Cedar Brook Financial Partners, LLC 104,881$86,0020.02%
PROFUND ADVISORS LLC 418,749$343,3740.02%
Arlington Capital Management, Inc. 27,735$22,7430.02%
Hennion & Walsh Asset Management, Inc. 382,158$3130.02%
Rafferty Asset Management, LLC 2,647,927$2,171,3000.02%
Brainard Capital Management LLC 16,666$13,6660.01%
Beck Bode, LLC 41,218$33,7990.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders